FENC
Fennec Pharmaceuticals Inc.
NASDAQ · USHealthcareBiotechnology
$9.90-5.71%
Price as of Jul 20, 2026
FENC profitability
Fennec Pharmaceuticals Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 92.2%
- EBITDA margin
- -13.1%
- EBIT margin
- -11.0%
- Net margin
- -16.4%
- Free cash flow margin
- -11.3%
Returns
- Return on equity
- -22.2%
- Return on assets
- -11.7%
- Return on invested capital
- -14.9%
- Asset turnover
- 0.72x
Cash efficiency
- Cash from operations
- -$5.8M
- Cash per share
- $1.16
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.